Skip to NavigationSkip to content

Pharmafile - Medical Communications News

Abbott has announced that the FDA has approved its Epic Max stented tissue valve to treat patients with aortic regurgitation or stenosis. The device...
The FDA has announced that it has approve Narcan, 4mg naloxone hydrochloride nasal spray for over-the-counter (OTC), non-prescription use. This is...
Japan-based NEC Corporation has announced that it is realigning its subsidiaries in order to streamline its AI drug development services. All will...
US-based Nanoscope Therapeutics has announced topline results from its phase 2b RESTORE clinical trial. Currently, patients with vision loss due to...
Hovione, a CDMO, and Laxxon Medical, a pharma-technology company, have signed a strategic partnership deal to bring 3D printing technologies to the...
Genialis, a computational precision medicine company, has announced that it’s raised more than $13m in Series A funding, co-led by Taiwania Capital...
The University of Dundee has announced its involvement in a Europe-wide project which will study whether AI can improve the outcomes of hypertension...
OctoVent, subsidiary of Hepalink Pharmaceutical Group, has entered into a license agreement with Taiwan-based Orient EuroPharma (OEP). The two...
Abberior has announced that it has placed a super-resolution STED microscope at MBC BioLabs, which is the leading San Francisco Bay Area biotech...
The FDA has released a draft of new guidance for accelerated approval for oncology therapeutics, highlighting the need for stricter clinical trial...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches